FGF21 serum concentrations showed a significant and positive association with insulin resistance and dyslipidemia including increased HOMA-IR, decreased adiponectin, and increased TG both in univariate and multivariate analysis. The gene discussed is ADIPOQ; the disease is metabolic syndrome.